Cargando…

Dramatic tumour response to pemetrexed single-agent in an elderly patient with malignant peritoneal mesothelioma: a case report

BACKGROUND: To date, there is no standard treatment for unresectable malignant peritoneal mesothelioma; either best supportive care or systemic chemotherapy with palliative intent are accepted options. CASE PRESENTATION: Here, we report the case of a 79-year old patient with malignant peritoneal mes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fasola, Gianpiero, Puglisi, Fabio, Follador, Alessandro, Aita, Marianna, Di Terlizzi, Silvia, Belvedere, Ornella
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764904/ https://www.ncbi.nlm.nih.gov/pubmed/17176466 http://dx.doi.org/10.1186/1471-2407-6-289

Ejemplares similares

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience
por: Bearz, Alessandra, et al.
Publicado: (2012)

Chemotherapy prescribing errors: an observational study on the role of information technology and computerized physician order entry systems
por: Aita, Marianna, et al.
Publicado: (2013)

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
por: Bijelic, Lana, et al.
Publicado: (2012)

STRN-ALK Rearranged Malignant Peritoneal Mesothelioma With Dramatic Response Following Ceritinib Treatment
por: Rüschoff, Jan H., et al.
Publicado: (2019)

Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation
por: Peitl, Milena, et al.
Publicado: (2017)

Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma
por: Otsuka, Yasuo, et al.
Publicado: (2023)

Drug waste minimisation and cost-containment in Medical Oncology: Two-year results of a feasibility study
por: Fasola, Gianpiero, et al.
Publicado: (2008)

Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma
por: Goudar, Ranjit K
Publicado: (2008)

Capecitabine-induced cardiotoxicity: more evidence or clinical approaches to protect the patients’ heart?
por: Fontanella, Caterina, et al.
Publicado: (2014)

Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example
por: Gerratana, Lorenzo, et al.
Publicado: (2016)

Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines
por: Monica, Valentina, et al.
Publicado: (2016)

Successful desensitization of pemetrexed-induced anaphylaxis in a patient with malignant mesothelioma
por: Youk, Jeonghwan, et al.
Publicado: (2017)

Upregulation of Thymidylate Synthase Induces Pemetrexed Resistance in Malignant Pleural Mesothelioma
por: Sato, Yuzo, et al.
Publicado: (2021)

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials
por: Ceresoli, G L, et al.
Publicado: (2008)

Malignant Peritoneal Mesothelioma
por: Fukunaga, Tomohiko, et al.
Publicado: (2022)

Genomic landscape of pleural and peritoneal mesothelioma tumours
por: Hiltbrunner, Stefanie, et al.
Publicado: (2022)

Polymorphisms in folate pathway and pemetrexed treatment outcome in patients with malignant pleural mesothelioma
por: Goricar, Katja, et al.
Publicado: (2014)

A Case Report of Primary Pericardial Malignant Mesothelioma Treated with Pemetrexed and Cisplatin
por: Kim, Jung Sun, et al.
Publicado: (2017)

Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: an in vitro study
por: Cova, Emanuela, et al.
Publicado: (2019)

Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly
por: Pan, Dan, et al.
Publicado: (2022)

Peritoneal Malignant Psammomatous Mesothelioma
por: Pusiol, Teresa, et al.
Publicado: (2010)

Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
por: Qin, Yiyang, et al.
Publicado: (2017)

Benign Multicystic Peritoneal Mesothelioma: A Rare Tumour of the Abdomen
por: Somasundaram, Soundappan, et al.
Publicado: (2015)

Fulminating septic shock from Clostridium perfringens in an early breast cancer patient with severe myalgia after docetaxel treatment
por: Minisini, Alessandro Marco, et al.
Publicado: (2011)

Synergistic anti-tumor effect of bullfrog sialic acid-binding lectin and pemetrexed in malignant mesothelioma
por: Satoh, Toshiyuki, et al.
Publicado: (2017)

In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes
por: Papazoglou, Eleftherios D., et al.
Publicado: (2019)

Interplay of non-coding RNAs and approved antimetabolites such as gemcitabine and pemetrexed in mesothelioma
por: Biersack, Bernhard
Publicado: (2018)

Treatment of Patients with Malignant Peritoneal Mesothelioma
por: Li, Claire Y., et al.
Publicado: (2022)

Peritoneal mesothelioma.
por: Kealey, W. D., et al.
Publicado: (1993)

Peritoneal mesothelioma.
por: Churg, J
Publicado: (1974)

Peritoneal mesothelioma
por: Greenbaum, Alissa, et al.
Publicado: (2020)

Drug waste minimization as an effective strategy of cost-containment in Oncology
por: Fasola, Gianpiero, et al.
Publicado: (2014)

Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
por: Kusamura, Shigeki, et al.
Publicado: (2023)

The role of folate receptor alpha (FRα) in the response of malignant pleural mesothelioma to pemetrexed-containing chemotherapy
por: Nutt, J E, et al.
Publicado: (2010)

Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
por: Ceresoli, G L, et al.
Publicado: (2013)

The effectiveness and safety of platinum-based pemetrexed and platinum-based gemcitabine treatment in patients with malignant pleural mesothelioma
por: Ak, Guntulu, et al.
Publicado: (2015)

Co-existing pericardial and pleural malignant mesothelioma responding well to nedaplatin and pemetrexed: a case report
por: Wu, Mindan, et al.
Publicado: (2023)

Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma
por: Røe, Oluf Dimitri, et al.
Publicado: (2012)

Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis
por: Mitsuka, Yuusuke, et al.
Publicado: (2010)

Malignant peritoneal mesothelioma. Is there a new treatment?
por: Rasul, Kakil Ibrahim, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_unfkavkcttk9a9c9cvlheaj26d